INTRODUCTION: The term cancer of unknown primary site (CUP) syndrome is used to describe malignancies in which a complete diagnostic work-up detects metastases in the absence of an identifiable primary tumor. METHODS: Based on a selective literature review, national and international guidelines, and the experience of the "Arbeitskreis CUP-Syndrom der Arbeitsgemeinschaft Internistische Onkologie der Deutschen Krebsgesellschaft" (CUP Syndrome Committee of the Medical Oncology Joint Working Group of the German Cancer Society), developments in the diagnosis and treatment of CUP syndrome are reported. RESULTS: Most patients diagnosed with CUP have an unfavorable prognosis, with a life expectancy of less than 12 months. Nevertheless, it is important to identify subsets of patients in whom specific treatment offers the chance of long-term survival or even full recovery. DISCUSSION: Only rigorous further development of diagnostic tools and treatment protocols will enable an improvement of the poor prognosis of patients with CUP syndrome. Specific molecular treatment strategies have shown promising results.
INTRODUCTION: The term cancer of unknown primary site (CUP) syndrome is used to describe malignancies in which a complete diagnostic work-up detects metastases in the absence of an identifiable primary tumor. METHODS: Based on a selective literature review, national and international guidelines, and the experience of the "Arbeitskreis CUP-Syndrom der Arbeitsgemeinschaft Internistische Onkologie der Deutschen Krebsgesellschaft" (CUP Syndrome Committee of the Medical Oncology Joint Working Group of the German Cancer Society), developments in the diagnosis and treatment of CUP syndrome are reported. RESULTS: Most patients diagnosed with CUP have an unfavorable prognosis, with a life expectancy of less than 12 months. Nevertheless, it is important to identify subsets of patients in whom specific treatment offers the chance of long-term survival or even full recovery. DISCUSSION: Only rigorous further development of diagnostic tools and treatment protocols will enable an improvement of the poor prognosis of patients with CUP syndrome. Specific molecular treatment strategies have shown promising results.
Entities:
Keywords:
CUP syndrome; diagnosis; metastasis; molecular medicine; treatment success
Authors: J Califano; W H Westra; W Koch; G Meininger; A Reed; L Yip; J O Boyle; F Lonardo; D Sidransky Journal: J Natl Cancer Inst Date: 1999-04-07 Impact factor: 13.506
Authors: I Petersen; A Hidalgo; S Petersen; K Schlüns; C Schewe; M Pacyna-Gengelbach; A Goeze; B Krebber; T Knösel; O Kaufmann; J Szymas; A von Deimling Journal: Brain Pathol Date: 2000-07 Impact factor: 6.508
Authors: Harald Löffler; Joe Puthenparambil; Thomas Hielscher; Kai Neben; Alwin Krämer Journal: Dtsch Arztebl Int Date: 2014-07-07 Impact factor: 5.594
Authors: Harald Löffler; Nicole Pfarr; Mark Kriegsmann; Volker Endris; Thomas Hielscher; Philipp Lohneis; Gunnar Folprecht; Albrecht Stenzinger; Manfred Dietel; Wilko Weichert; Alwin Krämer Journal: Oncotarget Date: 2016-07-12